ArticleCureus2026
Differential Proteomic Response to Smoking Exposure Underlies Reduced Parkinson's Disease Risk in Women.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The inverse association between cigarette smoking and Parkinson's disease (PD) risk, often termed the "smoker's paradox," remains one of the most reproducible observations in neuroepidemiology. Although multiple biological mechanisms have been proposed, the molecular correlates of smoking exposure in large human populations remain incompletely characterized. Methods We analyzed proteomic data from the UK Biobank Olink Explore 3072 platform to evaluate associations between cumulative smoking exposure and circulating proteins implicated in proteostasis, cellular stress responses, and neuronal biology. Sex-stratified linear regression models were performed with adjustment for age at recruitment. Results Among female participants, cumulative smoking exposure was associated with significantly higher circulating HSPA1A (HSP70) levels (p = 1.82 × 10⁻⁶), while BAG3 demonstrated a nominal positive association (p = 0.02). Independent analyses demonstrated that both smoking exposure (p = 0.0125) and circulating estradiol concentrations (p < 2 × 10⁻¹⁶) were associated with HSPA1A expression. No statistically significant smoking-by-estradiol interaction was observed (p = 0.3465). Additional associations involving BAG3 and CASP3 did not survive strict multiple-testing correction and should be considered exploratory. No significant associations were observed between smoking exposure and circulating dopa decarboxylase (DDC) levels. Conclusions Smoking exposure was associated with sex-specific differences in circulating proteomic biomarkers related to cellular stress-response and proteostasis pathways. These findings identify population-level proteomic signatures associated with cumulative smoking exposure and generate hypotheses for future mechanistic and longitudinal investigations. Because the study is observational and relies on peripheral blood biomarkers, the results should not be interpreted as evidence of causal neuroprotective mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.